Open Access

[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway

  • Authors:
    • Xuefeng Zhang
    • Na Liu
    • Danhua Ma
    • Ling Liu
    • Lu Jiang
    • Yu Zhou
    • Xin Zeng
    • Jing Li
    • Qianming Chen
  • View Affiliations

  • Published online on: January 4, 2022     https://doi.org/10.3892/ijo.2022.5301
  • Article Number: 11
  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2022
Volume 60 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Liu N, Ma D, Liu L, Jiang L, Zhou Y, Zeng X, Li J and Chen Q: [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway. Int J Oncol 60: 11, 2022
APA
Zhang, X., Liu, N., Ma, D., Liu, L., Jiang, L., Zhou, Y. ... Chen, Q. (2022). [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway. International Journal of Oncology, 60, 11. https://doi.org/10.3892/ijo.2022.5301
MLA
Zhang, X., Liu, N., Ma, D., Liu, L., Jiang, L., Zhou, Y., Zeng, X., Li, J., Chen, Q."[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway". International Journal of Oncology 60.2 (2022): 11.
Chicago
Zhang, X., Liu, N., Ma, D., Liu, L., Jiang, L., Zhou, Y., Zeng, X., Li, J., Chen, Q."[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway". International Journal of Oncology 60, no. 2 (2022): 11. https://doi.org/10.3892/ijo.2022.5301